CaLiGraph
Formats
RDF
N-Triples
N3/Turtle
JSON
XML
CSV
OData
Atom
JSON
Microdata
JSON
HTML
Embedded
JSON
Turtle
Browse using
OpenLink Faceted Browser
OpenLink Structured Data Editor
LodLive Browser
LODmilla Browser
Sparql Endpoint
About:
clgr:
Lorlatinib
Property
Value
rdf:
type
Antineoplastic drug
Receptor tyrosine kinase inhibitor
owl:
NamedIndividual
Fluoroarene
Lactam
Orphan drug
Pfizer brand
Pyridine
Drug granted breakthrough therapy designation
Pyrazole
rdfs:
label
Lorlatinib
owl:
sameAs
dbr:
Lorlatinib
prov:
wasDerivedFrom
http://en.wikipedia.org/wiki/Category:Orphan_drugs
http://en.wikipedia.org/wiki/Category:Pfizer_brands
http://en.wikipedia.org/wiki/Category:Pyridines
http://en.wikipedia.org/wiki/Category:Pyrazoles
http://en.wikipedia.org/wiki/ROS1
http://en.wikipedia.org/wiki/Category:Antineoplastic_drugs
http://en.wikipedia.org/wiki/Category:Fluoroarenes
http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation
http://en.wikipedia.org/wiki/Category:Lactams
http://en.wikipedia.org/wiki/Category:Receptor_tyrosine_kinase_inhibitors
skos:
prefLabel
Lorlatinib
skos:
altLabel
lorlatinib
clgo:
alternativeName
Lorbrena, Lorviqua
clgo:
bioavailability
81.0
clgo:
casNumber
1454846-35-5
clgo:
chEBI
143117
clgo:
drugbank
DB12130
clgo:
fdaUniiCode
OSP71S83EU
clgo:
kegg
D11012
clgo:
medlinePlus
a619005
clgo:
pubchem
71731823